Gender Affirming Hormone Therapy in Humans
Evidence from Murine Models
- 1st Edition - September 1, 2026
- Latest edition
- Editor: Jeffrey David Zajac
- Language: English
Gender Affirming Hormone Therapy in Humans: Evidence from Murine Models is an unprecedented reference for scientists, researchers, students and anyone interested in this field… Read more
Robotics & automation week
Empowering Progress
Up to 20% on Robotics and Automation Resources!
- Provides hot topics in cross gender hormone effects on the body
- Presents the most cutting-edge research models for future research innovation
- Includes science-based evidence and studies relevant to transgender research
- Highlights potential clinical approaches for the use of GAHT based on relevant up-to-date animal data
2. Male to Female and Female to Male models, controls
3. Cross gender hormone effects on bone
4. Cross gender hormone effects on the CVS and blood pressure
5. Cross gender hormone effects on the immune system
6. Cross gender hormone effects on muscle
7. Cross gender hormone effects on body composition
8. Cross gender hormone effects the kidney
9. Cross gender hormone effects on wound healing
10. Cross gender hormone effects on the CNS
11. Conclusion
- Edition: 1
- Latest edition
- Published: September 1, 2026
- Language: English
JZ
Jeffrey David Zajac
Jeffrey Zajac is Professor and Head of the University of Melbourne and Chair of Department of Medicine at Austin Health. He is a Clinical Endocrinologist and General Physician with research interests in molecular endocrinology.
Professor Zajac trained in Medicine at the University of Melbourne and undertook a PhD. Following postdoctoral work in the Endocrine Genetics Unit at Massachusetts General Hospital, Boston, he returned to the University of Melbourne initially at Royal Melbourne Hospital and now Austin Health. His research group has embarked on a major research program investigating the effect of androgen deprivation therapy in patients with prostate cancer. These investigations include effects on bone, muscle, cardiovascular risk and metabolic state. He also heads a molecular endocrinology group investigating the androgen receptor using genetically modified mice. His clinical interests include general endocrinology, the use, misuse and abuse of testosterone, and transgender medicine.